VANESSA ALBAN: Open Payments
NPI 1841883618 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 39 payments from 17 companies in 2025. Trend: 2023 $642 · 2024 $643 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $169 |
| Biogen, Inc. | 1 | $118 |
| Janssen Pharmaceuticals, Inc | 4 | $117 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Corium, LLC | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Alkermes, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Almatica Pharma LLC | 2 | $40 |
| Lundbeck LLC | 2 | $38 |
Products named: VRAYLAR, REXULTI, ZURZUVAE, SPRAVATO, Azstarys, FANAPT, LYBALVI, CAPLYTA.
Industry payments across FL — which companies pay providers there.
